Melatonin and Melatonergic Drugs in Clinical Practice 2013
DOI: 10.1007/978-81-322-0825-9_8
|View full text |Cite
|
Sign up to set email alerts
|

Multiple Facets of Melatonin in Immunity: Clinical Applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 262 publications
(169 reference statements)
0
3
0
Order By: Relevance
“…[ 67,68 ] Fasting glucose levels due to DLAN might be explained by the reduction in melatonin secretion, since melatonin has beneficial properties for the control of blood glucose levels in both rodents and humans. [ 69 ] In pinealectomyzed rats, increased basal glycemia [ 70 ] and significantly low expression and protein content of the insulin dependent glucose transporter 4 (GLUT4) was reported; [ 71 ] also increased hepatic gluconeogenesis is observed. [ 72 ] Interestingly both effects are reversed by melatonin replacement.…”
Section: Discussionmentioning
confidence: 99%
“…[ 67,68 ] Fasting glucose levels due to DLAN might be explained by the reduction in melatonin secretion, since melatonin has beneficial properties for the control of blood glucose levels in both rodents and humans. [ 69 ] In pinealectomyzed rats, increased basal glycemia [ 70 ] and significantly low expression and protein content of the insulin dependent glucose transporter 4 (GLUT4) was reported; [ 71 ] also increased hepatic gluconeogenesis is observed. [ 72 ] Interestingly both effects are reversed by melatonin replacement.…”
Section: Discussionmentioning
confidence: 99%
“…At present, there is no specific PNEI therapy for the autoimmune disease, since no clinical study has been carried out to explore the efficacy of a neuroimmune regimen to control their clinical progression, and in particular the possible therapeutic role of MLT still remains controversial, because of its potential immune-stimulatory action, even though it namely involves the cellular immunity rather than the humoral immunity, which represents the immune response most involved in the autoimmune diseases, since they are mainly due to an abnormal auto-antibody production. In any case, at present MLT has appeared to induce some therapeutic benefits in the treatment of bowel inflammatory diseases and some forms of systemic lupus erythematosous, whereas both improvement or worsening have been reported in MLT therapy of rheumatoid arthritis [29]. However, according to previous data concerning the pathogenesis of the autoimmune diseases, they could achieve some benefits from cannabinoid therapy, because of the inhibitory effects of cannabinoid agonists on IL-17 secretion, whose enhanced production plays a fundamental role in the induction of autoimmune diseaserelated inflammatory response [7].…”
Section: Neuroimmunotherapy Of Autoimmune Diseasesmentioning
confidence: 99%
“…On the other hand, from a neuroendocrine point of view, the autoimmune diseases would mainly depend on a hypo-activity of brain cannabinergic system, with a consequent possible enhanced production of IL-17, which is under a central inhibitory regulation exerted by the cannabinoid system and which plays a fundamental role in the induction of autoimmune response by activating the inflammatory response and by inhibiting T reg generation control [15]. As far as the pineal function in the autoimmunity is concerned, at present only few and controversial data are available, since both enhanced and diminished MLT secretion have been reported in association with alterations of its light/dark circadian rhythm [29]. Alterations of other endocrine and neuroendocrine circadian rhythms, namely that of cortisol, have been also observed in both metastatic cancer and autoimmune diseases [30] as a consequence of the increased secretion of proinflammatory cytokines, which stimulate HPA-axis [1,3].…”
Section: Pnei Pathogenesis Of Cancer and Autoimmune Diseasesmentioning
confidence: 99%